{"filing":{"accession_number":"0001404644-26-000040","cik":"0001404644","ticker":"NGNE","company_name":"Neurogene Inc.","form":"8-K","filing_date":"2026-06-04","report_date":null,"primary_document":"ngne-20260603.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1404644/000140464426000040/ngne-20260603.htm"},"events":[{"id":6879,"run_id":6028,"accession_number":"0001404644-26-000040","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for four proposals at Neurogene's June 3, 2026 Annual Meeting: election of two Class III directors (Robert Baffi and Rohan Palekar), advisory approval of named executive officer compensation, ratification of Deloitte \u0026 Touche LLP as auditor, and an advisory vote on the frequency of future compensation votes. The detailed vote tallies and quorum information are standard for this event type.","company_name":"Neurogene Inc.","ticker":"NGNE","filing_date":"2026-06-04","form":"8-K","submitted_at":null,"items":[{"id":4419,"accession_number":"0001404644-26-000040","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for four proposals at Neurogene's June 3, 2026 Annual Meeting: election of two Class III directors (Robert Baffi and Rohan Palekar), advisory approval of named executive officer compensation, ratification of Deloitte \u0026 Touche LLP as auditor, and an advisory vote on the frequency of future compensation votes. The detailed vote tallies and quorum information are standard for this event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:18:25.457707+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":4419,"accession_number":"0001404644-26-000040","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure of shareholder meeting results. The filing reports voting outcomes for four proposals at Neurogene's June 3, 2026 Annual Meeting: election of two Class III directors (Robert Baffi and Rohan Palekar), advisory approval of named executive officer compensation, ratification of Deloitte \u0026 Touche LLP as auditor, and an advisory vote on the frequency of future compensation votes. The detailed vote tallies and quorum information are standard for this event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-05T05:18:25.457707+00:00","company_name":"Neurogene Inc.","ticker":"NGNE","filing_date":"2026-06-04"}]}